Archive: Raymond J. March

Avatar Raymond J. March is a Research Fellow at the Independent Institute.
Worried About Big Pharma? Then Reduce the FDA’s Regulatory Power.
To compete for FDA attention, drug makers now needed a way to navigate new safety hurdles to have their products approved.
Raymond J. March | August 9, 2019
San Francisco’s Vaping Ban Is Doomed To Go Up in Smoke
Government efforts to regulate away vices can also motivate more dangerous or unhealthy behaviors.
Raymond J. March | July 6, 2019
Right-to-Try Legislation Helps Patient Battling Bone Cancer
After receiving access to experimental treatments, Natalie’s condition improved substantially.
Raymond J. March | July 2, 2019
FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression
Although much work remains to reverse the DEA’s overzealous scheduling system, Ketamine-based treatment for mental illness is another step in the right direction.
Raymond J. March | April 7, 2019
Healthcare Needs Price Competition, Not Just Transparency
Efforts to make healthcare costs more transparent are a good start. But transparency is no substitute for competition.
Raymond J. March | March 28, 2019
Raymond J. March | March 1, 2019
Right-to-Try’s First Rescue
A Patient with Terminal Brain Cancer Gets Treatment
Raymond J. March | February 13, 2019
If Teen Vaping Is Bad, the Alternative Is Worse
The FDA’s efforts to reduce teen vaping rates will likely result in worse health outcomes by prompting teens to switch to smoking cigarettes.
Raymond J. March | January 9, 2019
Evaporating Vaping Options
The FDA Moves to Regulate Away Consumer Choices
Raymond J. March | December 20, 2018
The FDA Loosens the Rules on Saving Lives
A Good Step, but Much More is Needed
Raymond J. March | November 21, 2018